Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › AHCY hydrolase inhibitors for treatment of hyper homocysteinemia

AHCY hydrolase inhibitors for treatment of hyper homocysteinemia

US Patent 8629275 · Granted Jan 14, 2014

Estimated economic value: $193,016,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydroquinazoline derivatives as selective cytotoxic agents2025
Pyrimidone derivatives as selective cytotoxic agents against HIV infected cells2025
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors2024
Tetrahydroquinazoline derivatives as selective cytotoxic agents2023
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2022
Antiviral benzyl-amine phosphodiamide compounds2021
3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetyla2021
Antiviral phosphodiamide prodrugs of tenofovir2020
Antiviral aryl-amide phosphodiamide compounds2020
Substituted quinolinones as PDE9 inhibitors2019
Phenyl-cyanoquinolinone PDE9 inhibitors2019
Oxy-cyanoquinolinone PDE9 inhibitors2019